MilliporeSigma
400 Summit Drive
Burlington, MA 01803
T: (800)-645-5476
Wwww.emdmillipore.com
Twitter: @MilliporeSigma
Facebook: @MilliporeSigma
LinkedIn: www.linkedin.com/company/milliporesigma/

 

An Industry-Leading Portfolio of Formulation Products

Our portfolio of formulation products includes excipients for solid, semi-solid and liquid dosage forms for small and large molecules, allowing you to formulate APIs to your exact specifications and requirements. We offer both customized manufacturing and a standard portfolio of synthetic lipids and functionalized PEGs, biodegradable polymers for sustained release of small and large molecules and functional excipients for excellent performance in tableting processes, solubility enhancement and controlled release. EMDMillipore.com/formulationapp

Synthetic Lipids for Pharmaceutical Applications

Lipid-based formulations and lipid nanoparticles are of increasing importance in drug development. We are highly specialized in synthesizing top-quality GMP lipids for pharmaceutical applications and gene therapy, focusing on tailored manufacturing to meet your specific needs. Our portfolio lipids include synthetic lipids with optimized stability, solubility, and handling characteristics. We supply GMP materials in quantities from grams to tons and support you through all phases of development, from R&D to commercialization. EMDMillipore.com/lipids

Synbiosys® Polymers for Modified-Release Formulation of Biologics

Formulating large biological APIs such as proteins and large peptides into long acting sustained release formulations has traditionally been a challenge for the pharma industry.
The SynBiosys® technology platform allows the encapsulation of biological therapeutics and controlled drug release – this helps to eliminate development hurdles. It is suitable for subcutaneous, intramuscular and site-specific injectable formulations with high API doses of up to 100 mg/mL and provides excellent lot-to-lot robustness and high production yields. EMDMillipore.com/polymericplatform

PLA & PLGA Polymers for Modified Release Formulations of Small Molecules & Selected Peptides

PLA and PLGA biodegradable polymers optimize and provide better control of the release kinetics of final drug products, supporting improved therapeutic efficacy, patient comfort and compliance. Choose your poly (D,L-lactic acid) (PLA) and poly (D,L-lactic-co-glycolic acid)(PLGA) polymer from our wide portfolio or let us provide a customized solution tailored to your individual needs. EMDMillipore.com/pla-plga